invEstigating oeStrogen Signalling and the Effect upoN the exTracelluar Matrix In pAtients With Obstructive Lung Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to understand the role of oestrogen in patients with asthma and Chronic Obstructive Pulmonary Disorder (COPD). Therefore, what is the effect of oestrogen in these participants compared to controls (those without disease). The study hypothesises that oestrogen loss in patients with asthma and COPD causes accelerated lung function decline and changes to lung structure. It will investigate if this is mediated by inflammation, immune host response or elastin and collagen changes. It is an observational prospective cohort study aiming to recruit healthy controls, and people with asthma or COPD), and/or the menopause.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: t
View:

• Men and women aged \> 18 years.

• For female participants: pre-menopausal, peri-menopausal and post-menopausal women can all be included.

• Participants willing and able to give informed consent for participation in the study.

• Healthy controls \<10 pack year history (participants without Asthma or COPD).

Locations
Other Locations
United Kingdom
Guys & St Thomas NHS Foundation Trust
RECRUITING
London
Contact Information
Primary
Gill Radcliffe Ms, MRes
gillian.radcliffe@gstt.nhs.uk
+442071888070
Backup
Chris Mwasuku
Christine.Mwasuku@gstt.nhs.uk
Time Frame
Start Date: 2024-12-01
Estimated Completion Date: 2028-11-01
Participants
Target number of participants: 100
Treatments
People with physician-diagnosed disease (Asthma and/or COPD).
People with physician-diagnosed disease (Asthma and/or COPD).
Healthy controls
People with no physician-diagnosed disease (Asthma and/or COPD).
Sponsors
Leads: Guy's and St Thomas' NHS Foundation Trust

This content was sourced from clinicaltrials.gov